Published March 29, 2022 | Version v1
Journal article Open

Domain Shifts in Machine Learning Based Covid‐19 Diagnosis From Blood Tests

  • 1. ELLIS Unit Linz, LIT AI Lab, Institute for Machine Learning, Johannes Kepler University Linz, Linz, Austria
  • 2. Department of Anesthesiology and Critical Care Medicine, Kepler University Hospital GmbH, Johannes Kepler University Linz, Linz, Austria
  • 3. RISC Software GmbH, Hagenberg i.M., Austria

Description

Abstract

Many previous studies claim to have developed machine learning models that diagnose COVID-19 from blood tests. How- ever, we hypothesize that changes in the underlying distribution of the data, so called domain shifts, affect the predictive performance and reliability and are a reason for the failure of such machine learning models in clinical application. Domain shifts can be caused, e.g., by changes in the disease prevalence (spreading or tested population), by refined RT-PCR testing procedures (way of taking samples, laboratory procedures), or by virus mutations. Therefore, machine learning models for diagnosing COVID-19 or other diseases may not be reliable and degrade in performance over time. We investigate whether domain shifts are present in COVID-19 datasets and how they affect machine learning methods. We further set out to esti- mate the mortality risk based on routinely acquired blood tests in a hospital setting throughout pandemics and under domain shifts. We reveal domain shifts by evaluating the models on a large-scale dataset with different assessment strategies, such as temporal validation. We present the novel finding that domain shifts strongly affect machine learning models for COVID-19 diagnosis and deteriorate their predictive performance and credibility. Therefore, frequent re-training and re-assessment are indispensable for robust models enabling clinical utility.

Files

domain shifts in machine learning.pdf

Files (1.4 MB)

Name Size Download all
md5:cbfbd01c0a6ffd38d689c1e8eb453f13
1.4 MB Preview Download

Additional details

Funding

European Commission
AIDD – Advanced machine learning for Innovative Drug Discovery 956832